324 related articles for article (PubMed ID: 20837699)
1. Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation.
Huggenberger R; Ullmann S; Proulx ST; Pytowski B; Alitalo K; Detmar M
J Exp Med; 2010 Sep; 207(10):2255-69. PubMed ID: 20837699
[TBL] [Abstract][Full Text] [Related]
2. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
3. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
4. An important role of lymphatic vessel activation in limiting acute inflammation.
Huggenberger R; Siddiqui SS; Brander D; Ullmann S; Zimmermann K; Antsiferova M; Werner S; Alitalo K; Detmar M
Blood; 2011 Apr; 117(17):4667-78. PubMed ID: 21364190
[TBL] [Abstract][Full Text] [Related]
5. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
[TBL] [Abstract][Full Text] [Related]
6. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis.
Guo R; Zhou Q; Proulx ST; Wood R; Ji RC; Ritchlin CT; Pytowski B; Zhu Z; Wang YJ; Schwarz EM; Xing L
Arthritis Rheum; 2009 Sep; 60(9):2666-76. PubMed ID: 19714652
[TBL] [Abstract][Full Text] [Related]
8. Lymphangiogenesis-independent resolution of experimental edema.
Ongstad EL; Bouta EM; Roberts JE; Uzarski JS; Gibbs SE; Sabel MS; Cimmino VM; Roberts MA; Goldman J
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H46-54. PubMed ID: 20207821
[TBL] [Abstract][Full Text] [Related]
9. Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis.
Kajiya K; Sawane M; Huggenberger R; Detmar M
J Invest Dermatol; 2009 May; 129(5):1292-8. PubMed ID: 19005491
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.
Roberts N; Kloos B; Cassella M; Podgrabinska S; Persaud K; Wu Y; Pytowski B; Skobe M
Cancer Res; 2006 Mar; 66(5):2650-7. PubMed ID: 16510584
[TBL] [Abstract][Full Text] [Related]
11. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.
Jones D; Xu Z; Zhang H; He Y; Kluger MS; Chen H; Min W
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2553-61. PubMed ID: 20864667
[TBL] [Abstract][Full Text] [Related]
12. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins.
Hong YK; Lange-Asschenfeldt B; Velasco P; Hirakawa S; Kunstfeld R; Brown LF; Bohlen P; Senger DR; Detmar M
FASEB J; 2004 Jul; 18(10):1111-3. PubMed ID: 15132990
[TBL] [Abstract][Full Text] [Related]
13. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.
Karpanen T; Wirzenius M; Mäkinen T; Veikkola T; Haisma HJ; Achen MG; Stacker SA; Pytowski B; Ylä-Herttuala S; Alitalo K
Am J Pathol; 2006 Aug; 169(2):708-18. PubMed ID: 16877368
[TBL] [Abstract][Full Text] [Related]
14. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
Pytowski B; Goldman J; Persaud K; Wu Y; Witte L; Hicklin DJ; Skobe M; Boardman KC; Swartz MA
J Natl Cancer Inst; 2005 Jan; 97(1):14-21. PubMed ID: 15632376
[TBL] [Abstract][Full Text] [Related]
15. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
16. AIP1 mediates vascular endothelial cell growth factor receptor-3-dependent angiogenic and lymphangiogenic responses.
Zhou HJ; Chen X; Huang Q; Liu R; Zhang H; Wang Y; Jin Y; Liang X; Lu L; Xu Z; Min W
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):603-15. PubMed ID: 24407031
[TBL] [Abstract][Full Text] [Related]
17. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
18. Chronic inflammation, lymphangiogenesis, and effect of an anti-VEGFR therapy in a mouse model and in human patients with aspiration pneumonia.
Nihei M; Okazaki T; Ebihara S; Kobayashi M; Niu K; Gui P; Tamai T; Nukiwa T; Yamaya M; Kikuchi T; Nagatomi R; Ebihara T; Ichinose M
J Pathol; 2015 Mar; 235(4):632-45. PubMed ID: 25348279
[TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenic growth factors, receptors and therapies.
Lohela M; Saaristo A; Veikkola T; Alitalo K
Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis.
Björndahl MA; Cao R; Burton JB; Brakenhielm E; Religa P; Galter D; Wu L; Cao Y
Cancer Res; 2005 Oct; 65(20):9261-8. PubMed ID: 16230387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]